Your browser doesn't support javascript.
loading
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.
Lheureux, S; Denoyelle, C; Ohashi, P S; De Bono, J S; Mottaghy, F M.
Affiliation
  • Lheureux S; Drug Development Program, Medical Oncology Princess Margaret Cancer Centre, Toronto, Canada. stephanie.lheureux@uhn.ca.
  • Denoyelle C; Normandie Univ, UNICAEN, Inserm, ANTICIPE (Interdisciplinary Research for Cancers Prevention and Treatment, axis 2 BioTICLA (Biology and Innovative Therapeutics for Locally Aggressive Cancers), 14000, Caen, France.
  • Ohashi PS; Comprehensive Cancer Center François Baclesse, UNICANCER, 14076, Caen, France.
  • De Bono JS; Department of Medical Biophysics, Department of Immunology, Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
  • Mottaghy FM; Drug Development Unit, The Institute of Cancer Research & The Royal Marsden NHS Trust, Sutton, UK.
Eur J Nucl Med Mol Imaging ; 44(Suppl 1): 41-54, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28396911
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Molecular Targeted Therapy / Neoplasms / Nuclear Medicine Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Physicians / Molecular Targeted Therapy / Neoplasms / Nuclear Medicine Limits: Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Type: Article Affiliation country: Canada